ARDELYX, INC.

For the period ended Sep 30, 2025. Filed Oct 30, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Oct 30, 2025

ARDX$2.93+1.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Statements of Changes in Stockholders’ Equity

(in thousands, except shares)

	Three Months Ended September 30, 2025
Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated Other Comprehensive (Loss) Income · Total Stockholders’ Equity
Shares · Amount
Balance as of June 30, 2025	240,765,516	$24	$1,085,108	$(945,563)	$(38)	$139,531
Issuance of common stock under employee stock purchase plan	162,859	—	703	—	—	703
Issuance of common stock upon exercise of options	860,811	—	2,111	—	—	2,111
Issuance of common stock upon vesting of restricted stock units	1,182,652	—	—	—	—	—
Stock-based compensation	—	—	12,742	—	—	12,742
Unrealized gains on available-for-sale securities	—	—	—	—	162	162
Net loss	—	—	—	(969)	—	(969)
Balance as of September 30, 2025	242,971,838	$24	$1,100,664	$(946,532)	$124	$154,280

	Nine Months Ended September 30, 2025
Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated Other Comprehensive Income · Total Stockholders’ Equity
Shares · Amount
Balance as of December 31, 2024	238,015,825	$24	$1,058,548	$(885,340)	$57	$173,289
Issuance of common stock under employee stock purchase plan	385,593	—	1,718	—	—	1,718
Issuance of common stock for services	87,256	—	315	—	—	315
Issuance of common stock upon exercise of options	1,641,801	—	3,566	—	—	3,566
Issuance of common stock upon vesting of restricted stock units	2,841,363	—	—	—	—	—
Stock-based compensation	—	—	36,517	—	—	36,517
Unrealized gains on available-for-sale securities	—	—	—	—	67	67
Net loss	—	—	—	(61,192)	—	(61,192)
Balance as of September 30, 2025	242,971,838	$24	$1,100,664	$(946,532)	$124	$154,280

	Three Months Ended September 30, 2024
Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated Other Comprehensive (Loss) Income · Total Stockholders’ Equity
Shares · Amount
Balance as of June 30, 2024	235,401,398	$23	$1,036,244	$(889,176)	$(101)	$146,990
Issuance of common stock under employee stock purchase plan	226,297	—	1,189	—	—	1,189
Issuance of common stock upon exercise of options	663,358	1	1,507	—	—	1,508
Issuance of common stock upon vesting of restricted stock units	599,378	—	—	—	—	—
Stock-based compensation	—	—	9,133	—	—	9,133
Unrealized gains on available-for-sale securities	—	—	—	—	286	286
Net loss	—	—	—	(809)	—	(809)
Balance as of September 30, 2024	236,890,431	$24	$1,048,073	$(889,985)	$185	$158,297

	Nine Months Ended September 30, 2024
Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated Other Comprehensive Income (Loss) · Total Stockholders’ Equity
Shares · Amount
Balance as of December 31, 2023	232,453,190	$23	$1,012,773	$(846,204)	$224	$166,816
Issuance of common stock under employee stock purchase plan	479,609	—	2,227	—	—	2,227
Issuance of common stock for services	40,549	—	257	—	—	257
Issuance of common stock upon exercise of options	2,227,627	1	5,298	—	—	5,299
Issuance of common stock upon vesting of restricted stock units	1,689,456	—	—	—	—	—
Stock-based compensation	—	—	27,518	—	—	27,518
Unrealized losses on available-for-sale securities	—	—	—	—	(39)	(39)
Net loss	—	—	—	(43,781)	—	(43,781)
Balance as of September 30, 2024	236,890,431	$24	$1,048,073	$(889,985)	$185	$158,297

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.